Current Knowledge on the Pathophysiology of Tuberculosis and Potential of Inhaled Bacteriophage Therapy Against Tuberculosis

Tuberculosis remains a major health burden around the world. With the emergence of multi-drug-resistant and extensively drug-resistant Mycobacterium tuberculosis, the need for alternative antimicrobial strategies has increased. Bacteriophages can specifically infect and lyse bacteria, thereby having the potential for the treatment of tuberculosis. Administration via pulmonary delivery may offer a means of concentrating viable bacteriophages at the infection site within the deep lung while reducing systemic exposure. This review examines the pathophysiological and intracellular barriers relevant to pulmonary TB and evaluates current strategies for aerosolized phage delivery, including nebulization, dry-powder formulations, and macrophage-targeted delivery systems. Preclinical studies demonstrate promising aerosol performance, intracellular delivery, and antimycobacterial activity, particularly through engineered dry powders and liposomal systems; however, direct clinical evidence in pulmonary TB remains limited. Major challenges include maintaining phage viability during aerosol generation and storage, penetrating granulomatous lesions, and delivering sufficient active phages to intracellular M. tuberculosis within alveolar macrophages. Future translation will depend on improving phage stability during aerosolization, achieving efficient alveolar and intracellular delivery, overcoming host and lesion barriers, and establishing standardized manufacturing, safety, and regulatory frameworks.

Authors

Institutions

Publication Details

Journal
Microorganisms
Published
2026-11-16
DOI
https://doi.org/10.3390/microorganisms14112652
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Current Knowledge on the Pathophysiology of Tuberculosis and Potential of Inhaled Bacteriophage Therapy Against Tuberculosis

Mary Garvey, Hak‐Kim Chan, Yu Lin, Yifan Long
5 links
Microorganisms
Tuberculosis Research and Epidemiology
article

Current Knowledge on the Pathophysiology of Tuberculosis and Potential of Inhaled Bacteriophage Therapy Against Tuberculosis

Mary Garvey, Hak‐Kim Chan, Yu Lin, Yifan Long
article en

Abstract

Tuberculosis remains a major health burden around the world. With the emergence of multi-drug-resistant and extensively drug-resistant Mycobacterium tuberculosis, the need for alternative antimicrobial strategies has increased. Bacteriophages can specifically infect and lyse bacteria, thereby having the potential for the treatment of tuberculosis. Administration via pulmonary delivery may offer a means of concentrating viable bacteriophages at the infection site within the deep lung while reducing systemic exposure. This review examines the pathophysiological and intracellular barriers relevant to pulmonary TB and evaluates current strategies for aerosolized phage delivery, including nebulization, dry-powder formulations, and macrophage-targeted delivery systems. Preclinical studies demonstrate promising aerosol performance, intracellular delivery, and antimycobacterial activity, particularly through engineered dry powders and liposomal systems; however, direct clinical evidence in pulmonary TB remains limited. Major challenges include maintaining phage viability during aerosol generation and storage, penetrating granulomatous lesions, and delivering sufficient active phages to intracellular M. tuberculosis within alveolar macrophages. Future translation will depend on improving phage stability during aerosolization, achieving efficient alveolar and intracellular delivery, overcoming host and lesion barriers, and establishing standardized manufacturing, safety, and regulatory frameworks.

MicroorganismsVol. 14(11)
The University of Sydney (AU), Chongqing Medical and Pharmaceutical College (CN), Atlantic Technological University (IE), Southern Medical University (CN)
Good health and well-being
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon